CAR T-cell therapy could be harnessed to treat heart disease
New study finds immunotherapy reduces cardiac fibrosis and restores heart function in mice after cardiac injury.
List view / Grid view
New study finds immunotherapy reduces cardiac fibrosis and restores heart function in mice after cardiac injury.
A study on how Polycombs regulate cellular identity could lead to alternative treatments for patients with drug-resistant cancer.
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
An animal model to test HIV infection in infants could lead to biomarkers that predict viral rebound after ART interruption.
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
Researchers have found a new way to treat the inflammation involved in chronic diseases.
Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life after treatment.
The gut microbiota has been linked to organ damage in patients with sepsis suggesting targeting intestinal microbiota may help patients' recovery.
New findings suggest a possible new treatment strategy for severe dengue disease using the tryptase inhibitor, nafamostat mesylate.
Targeting a deadly bacteria's use of succinate in the lungs could control infection and improve the health of people with cystic fibrosis.
Libraries of more than 9,000 macrocyclic molecules below 1 KDa have been generated, small enough to cross cell membranes and reach targets.
A new drug target for treating glioblastoma has been identified from a cellular pathway found to contribute to the spread of glioma stem cells.
A new study has identified possible regulators that determine differences in cancer tumours between genders.